Back to Search
KELLY MOORE, M.D., MPH
M.D., MPH
Public Health & General Preventive Medicine Physician
NPI: 1497965115Individual
Specialties, Licenses & Credentials
Public Health & General Preventive Medicine PhysicianPrimary
Preventive Medicine — Public Health & General Preventive Medicine
Code: 2083P0901X
36157(TN)
Research & Publications (20)
An anatomy of an infection: overview of the infectious process.
PMID 17338945·Crit Care Nurs Clin North Am·2007
6-review
The AIM Higher Initiative: new procedures implemented for assessment, information, and management of chemotherapy toxicities in community oncology clinics.
PMID 18390459·Clin J Oncol Nurs·2008
6-review
Hematopoietic support with moderately myelosuppressive chemotherapy regimens: a nursing perspective.
PMID 16789583·Clin J Oncol Nurs·2006
6-review
Duloxetine: a new approach for treating stress urinary incontinence.
PMID 15302567·Int J Gynaecol Obstet·2004
6-review
The tachykinin NK-2 receptor antagonist SR48968 does not block noncholinergic contractions in unstable human bladder.
PMID 12126745·Peptides·2002
8-other
Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
PMID 19456838·Clin Microbiol Infect·2010
8-other
Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy.
PMID 19121250·Mayo Clin Proc·2009
4-observational
Food security during infancy: implications for attachment and mental proficiency in toddlerhood.
PMID 18317892·Matern Child Health J·2009
8-other
Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
PMID 19041126·Gynecol Oncol·2009
8-other
Ultrastructural morphology and morphometry of phrenic nerve in rats.
PMID 19089905·Anat Rec (Hoboken)·2009
7-preclinical
Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
PMID 19118888·Gynecol Oncol·2009
4-observational
Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.
PMID 18948635·Arterioscler Thromb Vasc Biol·2009
7-preclinical
First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates.
PMID 18854490·J Pharmacol Exp Ther·2009
7-preclinical
Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation.
PMID 18985634·Stat Med·2009
8-other
Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.
PMID 19023029·Am J Physiol Gastrointest Liver Physiol·2009
8-other
Temporal regulation of Ath5 gene expression during eye development.
PMID 19059393·Dev Biol·2009
7-preclinical
Evolution of tertiary carbinamine BACE-1 inhibitors: Abeta reduction in rhesus CSF upon oral dosing.
PMID 19085994·ChemMedChem·2009
7-preclinical
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.
PMID 19114704·J Clin Oncol·2009
3-trial
N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
PMID 19114891·Crit Care Med·2009
2-rct
Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo.
PMID 19047058·J Biol Chem·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 425 5TH AVE N, 1ST FLOOR, CORDELL HULL BUILDING
NASHVILLE, TN 37243 - Phone
- (615) 741-7247
Quick Facts
- NPI
- 1497965115
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile